Smith & Nephew (SNN) Free Cash Flow (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Free Cash Flow of $172.0 million for Q4 2024, up 2.99% year-on-year from $167.0 million in Q1 2024, and up 2.99% on a QoQ basis from $167.0 million in Q4 2023.
Smith & Nephew (SNN) Free Cash Flow (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Free Cash Flow for 16 consecutive years, with $172.0 million the latest figure, recorded in Q4 2024.
- Quarterly Free Cash Flow rose 2.99% year-over-year to $172.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $172.0 million (down 66.41% YoY) and the FY2025 annual result came in at $852.0 million, up 40.59% from the prior year.
- Free Cash Flow improved to $172.0 million in Q4 2024 per SNN's latest filing, from $167.0 million in the prior quarter.
- Over the last five years, Free Cash Flow for SNN reached as high as $188.0 million in Q4 2020 and fell as low as $167.0 million in Q4 2023.
- A 5-year average of $175.0 million and a median of $173.0 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2020 — Free Cash Flow slumped 53.92% — and 2024, when it climbed 2.99%.
- Year by year, Free Cash Flow stood at $188.0 million in 2020, then fell by 6.91% to $175.0 million in 2021, then fell by 1.14% to $173.0 million in 2022, then retreated by 3.47% to $167.0 million in 2023, then gained by 2.99% to $172.0 million in 2024.
- According to Business Quant data, Free Cash Flow over the past three periods registered $172.0 million, $167.0 million, and $173.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 245.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 172.00 Mn |
| Dec 31, 2024 | 172.00 Mn |
| Dec 31, 2023 | 167.00 Mn |
| Dec 31, 2023 | 167.00 Mn |
| Dec 31, 2022 | 173.00 Mn |
| Dec 31, 2022 | 173.00 Mn |
| Dec 31, 2021 | 175.00 Mn |
| Dec 31, 2021 | 175.00 Mn |
| Dec 31, 2020 | 188.00 Mn |
| Dec 31, 2020 | 188.00 Mn |
| Dec 31, 2019 | 408.00 Mn |
| Dec 31, 2019 | 408.00 Mn |
| Dec 31, 2018 | 347.00 Mn |
| Dec 31, 2018 | 347.00 Mn |
| Dec 31, 2017 | 376.00 Mn |
| Dec 31, 2017 | 376.00 Mn |
| Dec 31, 2016 | 392.00 Mn |
| Dec 31, 2016 | 392.00 Mn |
| Dec 31, 2015 | 358.00 Mn |
| Dec 31, 2015 | 358.00 Mn |